Strategic Initiative
Slingshot members are tracking this corporate initiative:
Geron (GERN) Announces $80M License Deal with Janssen (JNJ) to Develop and Commercialize Products Based on GERN's Specialized Oligonucleotide Backbone Chemistry and RNA Interference Candidates for Treatment of Numerous Human Disorders
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Sep 19, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
License Deal, Specialized Oligonucleotide Backbone, Rna Interference Candidates, Numerous Human Disorders
